Teratoma surgery

Revision as of 20:16, 22 November 2019 by Gertrude Djouka (talk | contribs)
Jump to: navigation, search

Teratoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Teratoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Teratoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Teratoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Teratoma surgery

CDC on Teratoma surgery

Teratoma surgery in the news

Blogs on Teratoma surgery

Directions to Hospitals Treating Teratoma

Risk calculators and risk factors for Teratoma surgery


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]

Overview

Surgical intervention is the mainstay of treatment for teratoma.

Surgery

  • Surgical intervention is the mainstay of treatment for mature teratoma and immature teratoma stage I in children.[1][2][3]
  • Observation after surgery is very important with serial of follow up exams and serum alpha fetoprotein.[4]
  • Surgery with fertility sparing and chemotherapy are indicated for immature teratoma stage II-IV in aldults.[5]


References

  1. Tapper D, Lack EE (1983). "Teratomas in infancy and childhood. A 54-year experience at the Children's Hospital Medical Center". Ann Surg. 198 (3): 398–410. doi:10.1097/00000658-198309000-00016. PMC 1353316. PMID 6684416.
  2. Göbel, U.; Schneider, D. T.; Calaminus, G.; Haas, R. J.; Schmidt, P.; Harms, D. (2000). "Germ-cell tumors in childhood and adolescence". Annals of Oncology. 11 (3): 263–271. doi:10.1023/A:1008360523160. ISSN 0923-7534.
  3. Marina NM, Cushing B, Giller R, Cohen L, Lauer SJ, Ablin A; et al. (1999). "Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study". J Clin Oncol. 17 (7): 2137–43. doi:10.1200/JCO.1999.17.7.2137. PMID 10561269.
  4. Egler RA, Gosiengfiao Y, Russell H, Wickiser JE, Frazier AL (2017). "Is surgical resection and observation sufficient for stage I and II sacrococcygeal germ cell tumors? A case series and review". Pediatr Blood Cancer. 64 (5). doi:10.1002/pbc.26311. PMID 27786428.
  5. Norris HJ, Zirkin HJ, Benson WL (1976). "Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases". Cancer. 37 (5): 2359–72. doi:10.1002/1097-0142(197605)37:5<2359::aid-cncr2820370528>3.0.co;2-q. PMID 1260722.

Linked-in.jpg